Premier Path Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.56M Buy
24,762
+1,551
+7% +$409K 0.77% 28
2026
Q2
$5.9M Buy
23,211
+817
+4% +$190K 0.68% 33
2026
Q1
$5.47M Buy
22,394
+3,745
+20% +$872K 0.71% 33
2025
Q4
$3.86M Buy
18,649
+1,144
+7% +$226K 0.5% 40
2025
Q3
$3.25M Buy
17,505
+2,030
+13% +$348K 0.42% 53
2025
Q2
$2.36M Sell
15,475
-2,741
-15% -$421K 0.33% 70
2025
Q1
$3.02M Buy
18,216
+2,142
+13% +$335K 0.47% 48
2024
Q4
$2.32M Buy
16,074
+4,111
+34% +$637K 0.35% 64
2024
Q3
$1.94M Buy
11,963
+1,221
+11% +$195K 0.31% 80
2024
Q2
$1.57M Sell
10,742
-3,975
-27% -$591K 0.27% 92
2024
Q1
$2.32M Sell
14,717
-557
-4% -$88.7K 0.44% 52
2023
Q4
$2.39M Buy
+15,274
New +$2.34M 0.53% 37

Other funds holding JNJ

Premier Path Wealth Partners's JNJ Position: Q3 2026 in Review

Premier Path Wealth Partners increased its Johnson & Johnson (JNJ) stake by 6.7% in Q3 2026, buying an estimated $409K and bringing the position to 24,762 shares worth $6.56M. The position accounts for 0.77% of the portfolio, ranked #28.

Premier Path Wealth Partners first reported a position in JNJ in Q4 2023 and has held it in 12 quarters since. 1,611 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Premier Path Wealth Partners held 24,762 shares of Johnson & Johnson worth $6.56M as of Q3 2026.
  • Premier Path Wealth Partners bought 1,551 Johnson & Johnson shares in Q3 2026, an estimated $409K.
  • Johnson & Johnson made up 0.77% of Premier Path Wealth Partners's portfolio in Q3 2026, its #28 holding.
  • Premier Path Wealth Partners first reported a position in Johnson & Johnson in Q4 2023 and has held it in 12 quarters since.
  • 1,611 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.